Infusion Therapy

Viome Acquires Circulate Health, Closing the Loop Between Early Diagnostics, Precision Nutrition, and Treatment

Viome Life Sciences, a leading preventive health technology company, announces it has acquired Circulate Health, a pioneer of therapeutic plasma exchange (TPE) outside the hospital setting. Circulate’s protocols target healthspan and chronic disease, and include a proprietary approach to reducing microplastics in the body. The move unites Viome’s molecular diagnostic and precision nutrition platform with […]

Viome Acquires Circulate Health, Closing the Loop Between Early Diagnostics, Precision Nutrition, and Treatment Read More »

LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint

LUX Infusion, a clinician-led infusion services company, announces the acquisition of Infuse IQ, a trusted Wyoming-headquartered independent infusion therapy provider delivering safe, personalized infusion and injection treatments across a broad range of medical specialties. The acquisition expands LUX Infusion’s ambulatory infusion network and strengthens its ability to serve patients and referring providers in communities across

LUX Infusion Acquires Infuse IQ, Expanding Its National Ambulatory Infusion Footprint Read More »

CMS Opens New Doors at Home: Palliative Care, Home Infusion, and DMEPOS Changes in HH PPPS Proposed Rule

The calendar year (CY) 2027 Home Health Prospective Payment System (HH PPS) proposed rule offers an important glimpse into the Centers for Medicare & Medicaid Services’ (CMS’s) evolving vision for home-based care. Beyond the annual payment rate updates, CMS uses the proposed rule to advance several policy initiatives affecting home health agencies; durable medical equipment,

CMS Opens New Doors at Home: Palliative Care, Home Infusion, and DMEPOS Changes in HH PPPS Proposed Rule Read More »

Apex Infusion Partners with SkyKnight Capital

Apex Infusion (“Apex” or the “Company”), a leading omnichannel infusion services provider, has entered into a definitive agreement to partner with SkyKnight Capital, L.P. (“SkyKnight”), a private equity firm with a track record of building industry-defining businesses alongside exceptional management teams, to drive the Company’s next chapter of growth. Apex’s clinician-led management team will retain

Apex Infusion Partners with SkyKnight Capital Read More »

Bourne Brief: NICA Conference 2026 – Infusion Therapy Marketplace

The Bourne Partners team attended the National Infusion Center Association (NICA) Conference in Las Vegas to meet with executives and investors in the home and alternate site infusion therapy space. Altogether, Bourne Partners continues to consider home and alternate site infusion as one of the more attractive growth verticals in healthcare services with most providers

Bourne Brief: NICA Conference 2026 – Infusion Therapy Marketplace Read More »

Scroll to Top